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CMR in Myocarditis
Valuable Tool, Room for Improvement*
Godtfred Holmvang, MD, G. William Dec, MD
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aMyocarditis can be difficult to diagnose due to
varied clinical presentations, with onset ranging
from insidious to acute. Endomyocardial biopsy has
been the diagnostic “gold standard” but is now
seldom used due to the invasive nature, high rate of
sampling error, and variability in diagnostic criteria
and interpretation.
Over the last decade, a body of literature has
emerged that indicates a role for cardiac magnetic
resonance (CMR) in diagnosing acute myocarditis.
Sensitivity and specificity for myocarditis have been
demonstrated for 3 quantifiable magnetic resonance
See page 513
imaging (MRI) “tissue parameters”: 1) localized or
global/diffuse elevation of myocardial T2 signal
intensity (from tissue edema in inflammation);
2) excessive percent enhancement of myocardial T1
signal intensity early after injection of gadolinium
contrast (thought to reflect hyperemia with in-
creased vascular permeability and extracellular fluid
space in inflammation); and 3) abnormal late (“de-
layed”) myocardial enhancement (LE) post-
gadolinium (reflecting injury, necrosis, and fibrosis).
To account for variations in absolute signal inten-
sity due to technical factors, the first 2 parameters
are normalized by dividing with the T2 signal
intensity or the percent post-gadolinium enhance-
ment measured within skeletal muscle in the same
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Cardiology Division, Department of Medicine, Massachusetts Gen-d
eral Hospital, Boston, Massachusetts. Both authors have reported that they
have no relationships relevant to the contents of this paper to disclose.lice, yielding an edema ratio (ER) or global relative
nhancement (gRE) ratio, respectively.
The Journal of the American College of Cardiology
ublications supporting the use of CMR for diag-
osis of myocarditis include the 2006 Appropriate-
ess Criteria, the 2010 Multi-Society Expert Con-
ensus Document, and the 2009 White Paper (1).
he latter (1) reviewed all the data available to date
nd concluded that the CMR diagnostic perfor-
ance is best when all 3 of the afore-mentioned
equences are acquired, and they are considered
onsistent with myocarditis if at least 2 parameters
re abnormal. However, the data were believed to
e limited by relatively small studies with diverse
atient selection, imaging protocol, and diagnostic
riteria, and often absence of biopsy validation.
In this issue of iJACC, Lurz et al. (2) have
ndertaken a large and rigorous study to address
hese shortcomings. A total of 132 consecutive
atients with strong clinical suspicion of myocardi-
is prospectively underwent a comprehensive CMR
xamination for myocarditis, selective coronary an-
iography, and multiple left ventricular endomyo-
ardial biopsies. Biopsy analysis included histology,
mmunohistochemistry, and polymerase chain reac-
ion for viral genomic analysis.
Patients were divided on the basis of symptom
uration into 2 clinical groups: acute myocarditis
symptom duration 14 days; n  70) or chronic
yocarditis (symptom duration 14 days; n  62)
2). Within the acute group, a subgroup with
nfarct-like myocarditis was identified (chest pain,
T-segment elevation, and elevated troponin levels;
 37). The positive endomyocardial biopsy re-
ults were also divided into 2 histological groups:
cute (n  7) or chronic (n  75) myocarditis
etermined on the basis of the presence of myocyte
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526injury/necrosis versus fibrosis, respectively, accom-
panying the inflammatory infiltrate.
Left ventricular biopsy results demonstrated in-
flammation consistent with myocarditis in 83 of
132 patients (2). With this standard, the sensitivity,
specificity, and accuracy of CMR for diagnosing
myocarditis in the overall patient cohort was 76%,
54%, and 68%, respectively, when using the “2 of 3
criteria” approach. These figures improved to 81%,
71%, and 79%, respectively, in the patient group
with acute symptoms and improved further to 86%,
75%, and 84% in the subgroup with infarct-like
myocarditis. The authors’ explanation for this fa-
vorable trend is plausible: more acute and intense
symptoms may be expected to demonstrate increas-
ing myocardial edema, hyperemia, and injury/
necrosis, resulting in more definitive CMR abnor-
malities. For all 3 patient groups, sensitivity,
positive and negative predictive values, and overall
diagnostic accuracy are better using the 2 of 3
approach compared with any of the 3 parameters
individually.
This study (2) relies on endomyocardial biopsy to
make the correct diagnosis of myocarditis. How-
ever, the threshold of 14 leukocytes/mm2 involves a
ensitivity versus specificity trade-off of its own, and
he issue of biopsy sampling error is well known. In
n oft-quoted postmortem study of hearts from
atients who died with lymphocytic myocarditis,
his diagnosis could be demonstrated by using
istology from a single biopsy specimen only 17%
o 20% of the time (3). When the number of biopsy
pecimens was increased to 10, the diagnosis could
till be made only 55% to 63% of the time. This
ssue correlates with key information demonstrated
y delayed enhancement imaging: The lesions iden-
ified in myocarditis are almost invariably located in
he subepicardial to mid-myocardial layers of the
entricular wall, and are therefore not readily acces-
ible by endomyocardial biopsy. CMR offers a
lobal view of the myocardium, but when tested
gainst biopsy findings, a lower calculated accuracy
ecomes inevitable. A patient with myocarditis
hose MRI scan is positive and yet has a falsely
egative biopsy result will be erroneously counted as
false positive, which will lower the apparent
pecificity of CMR.
Other potential causes for false-positive CMR
tudies in the acute setting include stress-induced
takotsubo) cardiomyopathy and acute coronary
yndromes. Two of 3 MRI parameters evaluated in
yocarditis (the ER and gRE ratios) can reportedly
lso be abnormal in stress cardiomyopathy; how- Cver, late enhancement is generally not present (4).
ix of 84 patients with late enhancement in this
tudy showed a predominantly subendocardial pat-
ern. Subendocardial involvement has previously
een relied on to differentiate ischemic lesions from
yocarditis, and subendocardial infarction may oc-
asionally be seen in the absence of angiographically
ignificant epicardial coronary disease. Detailed an-
iographic data are not provided, nor do we know
he specific biopsy findings in these 6 patients.
Dividing the patients into “acute” and “chronic”
linical subgroups provides valuable information by
efining when current CMR techniques for detect-
ng myocarditis are less likely to be helpful. Impor-
antly, with symptoms lasting 14 days, the sensi-
ivity, specificity, and diagnostic accuracy of CMR
ere surprisingly poor (63%, 40%, and 52%, respec-
ively) (2). This unexpected finding questions the
tility of adding the full complement of myocarditis
equences to look for evidence of inflammation
hen CMR is done to evaluate unexplained heart
ailure, increasing ventricular ectopy, or dilated
ardiomyopathy of recent (but 14 days’) onset.
he basis for this lower performance with increas-
ng chronicity is likely 2-fold: as the authors sug-
est, chronicity is likely associated with a lower
ntensity of myocardial inflammation, making the
RI abnormalities more subtle, thereby lowering
ensitivity. Furthermore, the patient group with
ore insidious symptom onset will have a broad
nterface with a spectrum of other cardiac condi-
ions with similar clinical presentation and potential
or some overlap in MRI findings. For example, a
ide range of nonischemic conditions have been
dentified where myocardial delayed enhancement
s present. Mid-wall fibrosis associated with idio-
athic dilated cardiomyopathy or physiological hy-
ertrophy (e.g., in aortic stenosis), or even residual
brosis from a remote episode of myocarditis, could
ccasionally mimic myocarditis. Hypertrophic car-
iomyopathy or active cardiac sarcoidosis may dem-
nstrate delayed enhancement lesions that co-
ocalize with focal myocardial T2 hyperintensity.
nfiltrative cardiomyopathies such as amyloid, or
onceivably diffuse interstitial fibrosis found in
hronic heart failure of multiple etiologies, may
ause elevation of the gRE ratio. These situations
ncrease the odds of false-positive CMR studies for
yocarditis, which would lower specificity, and
igilance by the CMR reader regarding the possible
resence of other entities is always required.
This study (2) provides strong support for using
MR for confirmation when a diagnosis of myo-
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527carditis is entertained in patients who present with
acute (up to 14 days) onset of symptoms. It also
indicates a need for improvement before CMR can
be relied on to differentiate myocarditis from mul-
tiple other forms of heart disease when the presen-
tation is more chronic. This realistic assessment of
CMR for the diagnosis of myocarditis is enhanced
by the “real-world” design of this study, meaning
the unselected inclusion of “all comers” in whom
myocarditis is suspected, not acceptance of techni-
cally suboptimal studies. Quantitative accuracy of
the calculated parameters deteriorates if image qual-
ity becomes impaired, which undermines the diag-
nostic reliability of the examination. Incremental
gains in diagnostic performance of CMR may thus
be realized if gains in image quality are achieved, for
example, in new CMR-capable centers as they gain
broader experience. Development of more robust
pulse sequences is anticipated and should improve
image quality. Additional work is needed to deter-diol Img 2012;5:513–24.
3
4
2010;20:422–31.olds need to be adjusted for variations in technique,
such as use of alternative gadolinium agents or dose,
or performing the studies at different magnetic field
strengths (3.0-T instead of 1.5-T). Possible con-
founding of the normalized ER and gRE ratios if
there is associated skeletal muscle myositis could
ideally be addressed more rigorously. New ap-
proaches, such as T2- and possibly T1-mapping
echniques or use of macrophage-avid or other
argeted contrast agents, may provide additional
pportunities for CMR in the future to answer the
rucial question of whether myocardial inflamma-
ion is present or not among patients who present
ith heart failure/cardiomyopathy of more interme-
iate (longer than 14 days) duration.
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